Effects of the novel compound Hoe 065, a central enhancer of cholinergic activity, on voluntary alcohol consumption in rats

Hoe 065 is a compound structurally related to the angiotensin converting enzyme inhibitors and capable of increasing central cholinergic activity. The effects of this compound were studied on alcohol intake and on the reduction in alcohol intake produced by abutapril, an angiotensin converting enzyme inhibitor. Hoe 065 failed to alter alcohol intake or to modify the reduction in alcohol intake produced by abutapril. These findings suggest that enhanced cholinergic activity may not play a role in the control of alcohol consumption and may not be part of the mechanism by which the angiotensin converting enzyme inhibitors reduce alcohol intake.

[1]  L. Grupp,et al.  Angiotensin converting enzyme inhibitors reduce alcohol consumption: some possible mechanisms and important conditions for its therapeutic use. , 1990, Alcoholism, clinical and experimental research.

[2]  R. Stewart,et al.  Angiotensin II reduces voluntary alcohol intake in the rat , 1988, Pharmacology Biochemistry and Behavior.

[3]  L. Grupp,et al.  Management of Alcohol Consumption with Angiotensin Converting Enzyme Inhibitors: A Review of the Animal Findings , 1992 .

[4]  J. MacDonall,et al.  Increasing the rate of ethanol consumption in food- and water-satiated rats , 1979, Pharmacology Biochemistry and Behavior.

[5]  R. Mucha,et al.  Effects of desglycinamide(9)-lysine(8)-vasopressin and prolyl-leucyl-glycinamide on oral ethanol intake in the rat , 1979, Pharmacology Biochemistry and Behavior.

[6]  B. Costall,et al.  Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition , 1990, Brain Research.

[7]  C. Naranjo,et al.  Novel Pharmacological Interventions for Alcoholism , 1992, Springer New York.

[8]  R. Stewart,et al.  Ethanol as a reinforcer for rats: factors of facilitation and constraint. , 1988, Alcoholism, clinical and experimental research.

[9]  Zubenko Gs,et al.  Mood-elevating effect of captopril in depressed patients , 1984 .

[10]  R. Stewart,et al.  Angiotensin converting enzyme inhibitors: animal experiments suggest a new pharmacological treatment for alcohol abuse in humans. , 1988, Alcoholism, clinical and experimental research.

[11]  B. Costall,et al.  The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition , 1989, Pharmacology Biochemistry and Behavior.

[12]  R. Abhold,et al.  Elevations in plasma angiotensin II with prolonged ethanol treatment in rats , 1986, Pharmacology Biochemistry and Behavior.

[13]  F. Hock,et al.  Effects of Hoe 065, a compound structurally related to inhibitors of angiotensin converting enzyme, on acetylcholine metabolism in rat brain. , 1989, European journal of pharmacology.

[14]  F. Hock,et al.  Effects of the novel compound, Hoe 065, upon impaired learning and memory in rodents. , 1989, European journal of pharmacology.

[15]  B. Costall,et al.  Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro , 1989, Brain Research.